gefapixant
Ligand Summary
Gefapixant is a selective, non-narcotic P2X3 receptor antagonist being approved for the treatment of refractory chronic cough or unexplained chronic cough.
PubChem: 24764487
Guide to Pharmacology: 9540
ChEMBL: CHEMBL3716057
DrugCentral: 5519
LyCHI: 9HQF37JNJNW2
Target Activities
3 Activities
Items per page:
10
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
- | ||||||
IC50 | ||||||
IC50 | ANTAGONIST | |||||